ATE540968T1 - Alpha-fetoproteinpeptide und deren verwendungen - Google Patents

Alpha-fetoproteinpeptide und deren verwendungen

Info

Publication number
ATE540968T1
ATE540968T1 AT02791271T AT02791271T ATE540968T1 AT E540968 T1 ATE540968 T1 AT E540968T1 AT 02791271 T AT02791271 T AT 02791271T AT 02791271 T AT02791271 T AT 02791271T AT E540968 T1 ATE540968 T1 AT E540968T1
Authority
AT
Austria
Prior art keywords
modulators
amino acid
acid structures
methods
therapy
Prior art date
Application number
AT02791271T
Other languages
English (en)
Inventor
Thomas Andersen
James Bennett
Herbert Jacobson
Fassil Mesfin
Original Assignee
Albany Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albany Medical College filed Critical Albany Medical College
Application granted granted Critical
Publication of ATE540968T1 publication Critical patent/ATE540968T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02791271T 2001-11-20 2002-11-20 Alpha-fetoproteinpeptide und deren verwendungen ATE540968T1 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US33184101P 2001-11-20 2001-11-20
US34092601P 2001-12-07 2001-12-07
US39737302P 2002-07-19 2002-07-19
US39701202P 2002-07-19 2002-07-19
US40910902P 2002-09-09 2002-09-09
PCT/US2002/037070 WO2003044040A2 (en) 2001-11-20 2002-11-20 Alpha-fetoprotein peptides and uses thereof

Publications (1)

Publication Number Publication Date
ATE540968T1 true ATE540968T1 (de) 2012-01-15

Family

ID=27541106

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02791271T ATE540968T1 (de) 2001-11-20 2002-11-20 Alpha-fetoproteinpeptide und deren verwendungen

Country Status (6)

Country Link
US (1) US7122522B2 (de)
EP (1) EP1448593B1 (de)
AT (1) ATE540968T1 (de)
AU (1) AU2002365974A1 (de)
CA (1) CA2467756A1 (de)
WO (1) WO2003044040A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7943577B2 (en) * 2001-11-20 2011-05-17 Albany Medical College Alpha-fetoprotein peptides and uses thereof
CN1871252A (zh) * 2003-09-05 2006-11-29 Gtc生物治疗学公司 在转基因哺乳动物奶中生产融合蛋白的方法
SE0401302D0 (sv) * 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Inhibition of erk-phosphorylation
US7964701B2 (en) 2006-02-24 2011-06-21 Albany Medical College Alpha-fetoprotein peptides
US7598342B2 (en) * 2006-02-24 2009-10-06 Albany Medical College Alpha-fetoprotein peptides and uses thereof
US9249189B2 (en) * 2010-01-18 2016-02-02 Albany Medical College Alpha-fetoprotein “ring and tail” peptides
CN102628869B (zh) * 2012-04-19 2014-04-02 上海蓝怡科技有限公司 提高甲胎蛋白抗体冻干稳定性的制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674842A (en) 1994-10-26 1997-10-07 Health Research, Incorporated Growth inhibitory peptide
EP1005357A1 (de) 1997-04-14 2000-06-07 The Regents Of The University Of California Peptid antiöstrogen-zusammensetzungen und verfahren zur behandlung des brustkrebses
EP1401467B3 (de) * 2001-06-02 2014-02-26 Albany Medical College Alpha-fetoprotein-peptide und ihre verwendung

Also Published As

Publication number Publication date
WO2003044040A2 (en) 2003-05-30
AU2002365974A1 (en) 2003-06-10
US20060199769A1 (en) 2006-09-07
CA2467756A1 (en) 2003-05-30
EP1448593B1 (de) 2012-01-11
AU2002365974A8 (en) 2003-06-10
WO2003044040A3 (en) 2004-01-22
US7122522B2 (en) 2006-10-17
WO2003044040A9 (en) 2005-01-06
EP1448593A4 (de) 2006-08-30
EP1448593A2 (de) 2004-08-25

Similar Documents

Publication Publication Date Title
CN101370821B (zh) 新型肽及其用途
KR970707141A (ko) 종양 괴사 인자-감마(Tumor necrosis factor-gamma)
ES2389670T3 (es) Uso del PIG para el tratamiento de trastornos asociados a la transmisión sináptica desfuncional
DE60327786D1 (de) Kdr-peptide und diese enthaltende impfstoffe
HK1069316A1 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
CA2596597A1 (en) Method for stimulation collagen synthesis and/or kgf expression
HK1077518A1 (en) Peptides that modulate nerve growth factor (ngf) activity, their compositions and use
IL161591A (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
IL197686A0 (en) Pharmaceutical compositions containing alpha-4 integrin antagonists and uses thereof in the treatment of multiple myeloma and diseases associated therewith
BR0110049A (pt) Agonista de cxcr4, uso de um agonista de cxcr4, e composição farmacêutica
BRPI0406796A (pt) Métodos para tratar hipertrofia prostática benigna, para reduzir um sintoma associado com a mesma, para reduzir o tamanho da próstata em um indivìduo humano e para profilaxia de bhp, composição farmacêutica oral de dose unitária, e, uso de lonidamina ou um análogo de lonidamina
ATE152628T1 (de) Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
ATE540968T1 (de) Alpha-fetoproteinpeptide und deren verwendungen
CA2449284A1 (en) Alpha-fetoprotein peptides and uses thereof
MXPA00010254A (es) Tratamiento de disfuncion sexual en ciertos grupos de pacientes.
ES2569552T3 (es) Composiciones de péptido de MNTF y métodos de uso
GB9930768D0 (en) Composition
YU60199A (sh) Nove soli bpc peptida sa organo-zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena u terapiji
ES2842523T3 (es) Métodos y composiciones para el tratamiento de la artritis
EP1282641A4 (de) MENSCHLICHES, GEBäRMUTTERKREBS-SPEZIFISCHES SUPPRESSORPROTEIN, FüR DAS PROTEIN KODIERES POLYNUKLEOTID, MIT DEM POLYNUKLEOTID TRANSFORMIERTE ZELLE UND VERFAHREN ZUR UNTERDRüCKUNG DER PROLIFERATION VON KREBSZELLEN UNTER VERWENDUNG DES EXPRESSIONSVEKTORS
HK1092162A1 (en) Biologically active peptides comprising isoleucyl-valyl-threonyl- asparaginyl-threonyl-threonine (ivtntt)
RU2776047C1 (ru) Способ индуцирования селективной медикаментозной абляции предстательной железы без повреждения нервов и с сохранением половой функции
WO2001087039A3 (en) Treatment of neoplasia / transformation using pituitary tumor transforming gene 2
WO2024057793A1 (ja) 癌転移を抑制するシトルリン化ペプチド
RU2780890C2 (ru) Способ лечения доброкачественной гиперплазии предстательной железы с помощью антибиотиков